AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Acrivon Therapeutics, Inc. Common Stock

$1.66 -$0.80 (-32.52%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$1.76
Day Range
$1.64$1.73
Year Range
$1.27$3.56
Market Cap
71.14M
AVG Volume
338.43K
Trailing/Forward PE
-0.88/-
PEG ratio
0.1
Dividend Yield
-
Next Earnings Date
2026-11-12
Primary Exchange
NASDAQUS
Net Income (USD) · A
-100M-75M-50M-25M02022202320242025
ACRV Net Income (USD) by year
PeriodNet Income (USD)
2025-77.91M
2024-80.56M
2023-60.39M
2022-31.17M
Operating Income (USD) · A
-100M-75M-50M-25M02022202320242025
ACRV Operating Income (USD) by year
PeriodOperating Income (USD)
2025-84.11M
2024-89.2M
2023-67.1M
2022-32.66M
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: ACRV

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 12 Nov 2026.

Acrivon Therapeutics, Inc. Common Stock
ACRV
Stockpicker

Video analysis: ACRV

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: ACRV

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.